Skip to main content

Matt Sinclair

In the news

  • Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut. The drug, called lolamicin, also warded off secondary infections with Clostridioides...
  • Graduate students, research scientists, and faculty gathered at the I Hotel and Conference Center earlier this month for the School of Molecular & Cellular Biology’s Graduate Research Retreat. The event brought together scholars from across the school to share scientific discoveries and learn...